GSK2245035

DB16076InvestigationalSmall molecule

GSK2245035 is under investigation in clinical trial NCT02833974 (Effect of the GSK2245035 on the Allergen-induced Asthmatic Response).

Mechanism: Pharmacologically active on Toll-like receptor 7
Curator reviewed
Formula / weight: C₂₀H₃₄N₆O₂ · 390.532 g/mol (avg)
Code names: GSK-2245035

Resolves to

Compound

Structure

InChIKeyLFMPVTVPXHNXOT-HNNXBMFYSA-NSMILESCCC[C@H](C)OC1=NC(N)=C2NC(=O)N(CCCCCN3CCCCC3)C2=N1

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

4Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with GSK2245035, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.